How Open Source Drug Discovery can lower the risk and cost of drug discovery. M4K Pharma is pioneering a completely new model, where patents are not filed but data is shared. Yet they are still able to make money.

Bio2040 - Bottlenecks & Future of Healthcare & Drug Discovery

11 Open Source Drug Discovery with M4K Pharma's Owen Roberts

In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of drug discovery by speaking with some of the sharpest, most innovative minds in drug discovery, biotechnology and related fields. We talk about machine learning for high-throughput screening, open source drug discovery and other trends that are changing how drug discovery gets done.

About

Bio2040 - Bottlenecks & Future of Healthcare & Drug Discovery